Skip to Content Skip to Content

Health Sciences

Reset All Filters
2004 Results
Most Women are Unaware of New Guidelines for Pap Test Frequency, Penn Medicine Study Reveals

Most Women are Unaware of New Guidelines for Pap Test Frequency, Penn Medicine Study Reveals

Women know that Pap tests are a useful screening test for cervical cancer, but according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvania, most of those surveyed are unaware of the updated screening guidelines for the appropriate frequency of Pap tests in low-risk women.

Katie Delach

Penn Team Finds Protein "Cement" that Stabilizes the Crossroad of Chromosomes

Penn Team Finds Protein "Cement" that Stabilizes the Crossroad of Chromosomes

Cell division is the basis of life and requires that each daughter cell receive the proper complement of chromosomes. In most organisms, this process is mediated at the familiar constricted intersection of X-shaped chromosomes. This area, called the centromere, is where special proteins gather and attach to pull daughter cells apart during cell division.

Karen Kreeger

Penn Researchers Develop Custom Artificial Membranes to Study the Molecular Basis of Disease

Penn Researchers Develop Custom Artificial Membranes to Study the Molecular Basis of Disease

By Madeleine Stone  @themadstone        Decorating the outside of cells like tiny antenna, a diverse community of sugar molecules acts like a telecommunications system, sending and receiving information, recognizing and responding to foreign molecules and neighboring cells.

Evan Lerner

Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening

Penn Medicine Study Reveals Why Almost Half of At-Risk Patients Opt Out of Comprehensive Multiplex Cancer Screening

Some at-risk patients opted out of comprehensive cancer gene screening when presented with the opportunity to be tested for the presence of genes linked to various cancers, according to a recent study led by researchers at the Perelman School of Medicine at the University of Pennsylvania and the 

Katie Delach

Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia

Penn-Michigan State Team Develops Novel Gene Therapy for Achromatopsia

Researchers from the University of Pennsylvania and Michigan State University presented new preclinical data this week that evaluates the efficacy of a gene therapy treatment for achromatopsia, a rare inherited retinal disease that involves cone cells. The disease affects humans as well as dogs.

Katherine Unger Baillie

Off-Label Use of Device to Prevent Stroke in A-Fib Patients is Prevalent and Potentially Dangerous, According to Penn Medicine Study

Off-Label Use of Device to Prevent Stroke in A-Fib Patients is Prevalent and Potentially Dangerous, According to Penn Medicine Study

The Lariat device, which has been cleared by the U.S. Food and Drug Administration (FDA) for soft tissue approximation (placement of a suture) during surgical procedures, is associated with a significant incidence of death and urgent cardiac surgery during its frequent off-label use to prevent stroke in patients with the irregular heartbeat known as atrial fibrillation.

Anna Duerr

Penn Study Indicates that Gene Therapy Efficacy for LCA is Dynamic: Improvement is Followed by Decline in Vision

Penn Study Indicates that Gene Therapy Efficacy for LCA is Dynamic: Improvement is Followed by Decline in Vision

Gene therapy for Leber congenital amaurosis (LCA), an inherited disorder that causes loss of night- and day-vision starting in childhood, improved patients’ eyesight within weeks of treatment in a clinical trial of 15 children and adults at the Scheie Eye Institute at the Perelman School of Medicine at the University of Pennsylvania.

Lee-Ann Donegan